Behrens K, Stegner H E
Geburtshilfe Frauenheilkd. 1987 Apr;47(4):254-66. doi: 10.1055/s-2008-1035818.
In the period between 1972 and 1984 716 cervical carcinomas, of which 78 were glandular cancers, were diagnosed at the University Hospital in Hamburg-Eppendorf. The incidence of invasive adenocarcinomas of the cervix is 10.9%. When compared with a study published in 1949 (19) the incidence of adenocarcinoma has risen from 3% to 10.9%. In the period of observation, i.e., from 1972 to 1984, no trend to an increase in incidence was observed. The average age of the patients, 62.6 years, is relatively high in comparison with other studies. An earlier onset of disease has not been observed. The available data do not provide any evidence of connection between the use of oral contraceptives and later development of an adenocarcinoma. The five-year survival rate for all stages taken together was 40.4%. The five-year survival rate, and thus the prognosis for glandular carcinomas of the cervical glands, depends primarily on the clinical stage of the disease, though also on the histological type and the degree of differentiation of the tumor.
1972年至1984年间,汉堡-埃彭多夫大学医院诊断出716例宫颈癌,其中78例为腺癌。宫颈浸润性腺癌的发病率为10.9%。与1949年发表的一项研究相比,腺癌的发病率已从3%上升至10.9%。在观察期(即1972年至1984年)内,未观察到发病率上升的趋势。患者的平均年龄为62.6岁,与其他研究相比相对较高。未观察到疾病发病年龄提前的情况。现有数据未提供任何证据表明口服避孕药的使用与后来发生腺癌之间存在关联。所有分期的综合五年生存率为40.4%。五年生存率,也就是宫颈腺癌的预后,主要取决于疾病的临床分期,不过也取决于肿瘤的组织学类型和分化程度。